文献速递心血管CT

疑似急性冠脉综合征患者冠状动脉周围脂肪组织衰减的诊断与预后价值:RAPID-CTCA试验的启示

Diagnostic and Prognostic Performance of Pericoronary Adipose Tissue Attenuation in Suspected Acute Coronary Syndrome: Insights from the RAPID-CTCA Trial.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

该研究为RAPID-CTCA试验的事后分析,纳入353例疑似急性冠脉综合征的中危患者,评估冠状动脉周围脂肪组织衰减(PCAT)在诊断急性冠脉综合征及预测1年预后方面的价值。结果显示,PCAT的诊断区分能力较弱(C统计量0.57),且未增加诊断区分度;在预后方面,PCAT衰减是死亡或再发心肌梗死的独立预测因子(校正HR 1.12),但加入LAP负荷后未改善事件区分度(ΔC统计量0;95%CI:-0.11,0.11;P=0.97)。

要点

  • PCAT衰减诊断ACS的C统计量为0.57,未提供额外诊断区分度(P>0.05)。
  • PCAT衰减是1年死亡或再发心梗的独立预测因子(校正HR 1.12;95%CI:1.00,1.26)。
  • PCAT衰减加入LAP负荷后未改善事件区分度(ΔC统计量0;95%CI:-0.11,0.11;P=0.97)。

核心结论

  • 在中危疑似ACS患者中,PCAT衰减的诊断和预后性能较弱,与GRACE评分或其他CCTA指标相比更差或无额外价值。

研究设计与样本

  • 多中心前瞻性随机试验(RAPID-CTCA,NCT02284191)的二次事后分析,纳入英国37个中心的353例中危疑似ACS患者,采用ROC曲线分析和Cox比例风险回归评估PCAT衰减、GRACE评分、冠状动脉直径狭窄和低衰减斑块负荷的诊断与预后性能。

诊断标准与关键数值

  • 诊断ACS的C统计量:直径狭窄0.74,LAP负荷0.73,GRACE评分0.62,PCAT衰减0.57(PCAT未提供额外诊断区分度,所有比较P>0.05)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To assess whether pericoronary adipose tissue (PCAT) attenuation on coronary CT angiography (CCTA) aids in the diagnosis of acute coronary syndrome (ACS) or provides additive prognostic value at 1 year in intermediate-risk individuals. Materials and Methods This study was a secondary post hoc analysis of the multicenter prospective randomized Rapid Assessment of Potential Ischemic Heart Disease with CT Coronary Angiography trial (ClinicalTrials.gov identifier, NCT02284191), which enrolled intermediate-risk patients with suspected ACS from 37 sites in the United Kingdom between March 2015 and June 2019. The current study evaluated the diagnostic and prognostic performance of PCAT attenuation, the Global Registry of Acute Coronary Events (GRACE) score, coronary artery diameter stenosis, and low-attenuation plaque (LAP) burden, using receiver operating characteristic curve analysis and Cox proportional hazards regression, respectively. Results The study included 353 participants (median age, 63 years [IQR, 54-73 years]; 231 [65%] male participants), of whom 169 (48%) had a discharge diagnosis of ACS. The strongest predictors were diameter stenosis (C statistic, 0.74) and LAP burden (C statistic, 0.73), followed by the GRACE score (C statistic, 0.62). PCAT attenuation (C statistic, 0.57) did not provide additive discrimination for diagnosis (P > .05 for all comparisons). Both LAP burden (adjusted hazard ratio, 1.16; 95% CI: 1.02, 1.32) and PCAT attenuation (adjusted hazard ratio, 1.12; 95% CI: 1.00, 1.26) were independent predictors of death or recurrent myocardial infarction at 1 year. However, adding PCAT attenuation (C statistic, 0.63; 95% CI: 0.50, 0.76) to LAP burden (C statistic, 0.69; 95% CI: 0.62, 0.77) did not improve event discrimination (ΔC statistic, 0; 95% CI: -0.11, 0.11; P = .97). Conclusion In intermediate-risk individuals with suspected ACS, PCAT attenuation showed weak diagnostic and prognostic performance, inferior or nonadditive compared with the GRACE score or other CCTA metrics. Keywords: Pericoronary Adipose Tissue Attenuation, Acute Chest Pain, CT Coronary Angiography Supplemental material is available for this article. Clinical trial registration no. NCT02284191 © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Lakshmanan S, Wang KL, Meah MN, et al. Diagnostic and Prognostic Performance of Pericoronary Adipose Tissue Attenuation in Suspected Acute Coronary Syndrome: Insights from the RAPID-CTCA Trial. Radiol Cardiothorac Imaging. 2026. PMID: 41504639. doi:10.1148/ryct.250074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。